dihexa hgf/c-met potentiator

dihexa hgf/c-met potentiator Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer Dihexa 20mg Qty25 – NewBioRx

Name: dihexa hgf/c-met potentiator Molecular mechanism(s) of regulation(s) of c-MET/HGF signaling in head and neck cancer | Molecular Cancer Dihexa 20mg Qty25 – NewBioRx
Brand: equiscorp.hu
SKU: 70572964680
Price: 23.78 USD
Availability: InStock
Rating: 4.5913 (15 reviews)

Dihexa 20mg Qty25 NewBioRx Correlation between hypoxia and HGF c MET expression in the management of pancreatic cancer ScienceDirect The HGF c Met Axis: A Promising Therapeutic Target in Cancer Frontiers Research Topic Small Molecule AngIV based Analogs to Treat Alzheimers Disease

SKU: 70572964680 · From equiscorp.hu

4.6

USD23.78 USD49.78

Pay in 4 interest-free payments of $5.95 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 3 - Aug 8

Description

Other cell lines such as MiaPaCa-2, Panc-1 and BxPC3 have been used in studies published by us and others 5,6 to demonstrate that the presence of PSCs accelerates cancer progression in a manner similar to that with AsPC-1 (thus the orthotopic model itself would not be different with different cell lines)